Among patients with a severe, life-threatening type of sclerosis, treatment with hematopoietic stem cell transplantation , compared to intravenous infusion of the chemotherapeutic drug cyclophosphamide, was associated with an increased treatment-related risk of death in the first year, but better long-term survival, according to a study in JAMA .
http://ift.tt/TtxY0y
http://ift.tt/TtxY0y
No comments:
Post a Comment